Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cassone

Showing results (171-180 of 218) with videos related to

Pageof 22
Sort By:
Journal of Biological Regulators and Homeostatic Agents|April 11, 2006
60-kDa heat shock protein of Chlamydia pneumoniae is a target of T-cell immune responseC M Ausiello, R Palazzo, F Spensieri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1996
Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strainsC Girmenia, P Martino, F De Bernardis, et al.
Cellular Immunology|June 25, 1998
Interaction between human interleukin-2-activated natural killer cells and heat-killed germ tube forms of Candida albicansG Arancia, A Stringaro, P Crateri, et al.
Journal of Medical Microbiology|November 1, 1986
Proliferation of human peripheral blood mononuclear cells induced by Candida albicans and its cell wall fractionsC M Ausiello, G C Spagnoli, M Boccanera, et al.
Nature Biotechnology|February 1, 1997
Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activityW Magliani, S Conti, F de Bernardis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1996
Human natural yeast killer toxin-like candidacidal antibodiesL Polonelli, F De Bernadis, S Conti, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
Induction of immunosuppressive B-lymphocytes with components of Candida albicansC F Cuff, B Packer, V Rivas, et al.
The Journal of Infectious Diseases|June 1, 1990
Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasisF De Bernardis, L Agatensi, I K Ross, et al.
Medical Mycology|February 13, 1999
Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute?A Casadevall, A Cassone, F Bistoni, et al.
Journal of Chemotherapy (Florence, Italy)|September 20, 2005
Glucan-associated protein modulations and ultrastructural changes of the cell wall in Candida albicans treated with micafungin, a water-soluble, lipopeptide antimycoticL Angiolella, B Maras, A R Stringaro, et al.
Pageof 22

Showing results (171-180 of 218) with videos related to

Sort By:
Pageof 22
Journal of Biological Regulators and Homeostatic Agents|April 11, 2006
60-kDa heat shock protein of Chlamydia pneumoniae is a target of T-cell immune responseC M Ausiello, R Palazzo, F Spensieri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1996
Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strainsC Girmenia, P Martino, F De Bernardis, et al.
Cellular Immunology|June 25, 1998
Interaction between human interleukin-2-activated natural killer cells and heat-killed germ tube forms of Candida albicansG Arancia, A Stringaro, P Crateri, et al.
Journal of Medical Microbiology|November 1, 1986
Proliferation of human peripheral blood mononuclear cells induced by Candida albicans and its cell wall fractionsC M Ausiello, G C Spagnoli, M Boccanera, et al.
Nature Biotechnology|February 1, 1997
Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activityW Magliani, S Conti, F de Bernardis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1996
Human natural yeast killer toxin-like candidacidal antibodiesL Polonelli, F De Bernadis, S Conti, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
Induction of immunosuppressive B-lymphocytes with components of Candida albicansC F Cuff, B Packer, V Rivas, et al.
The Journal of Infectious Diseases|June 1, 1990
Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasisF De Bernardis, L Agatensi, I K Ross, et al.
Medical Mycology|February 13, 1999
Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute?A Casadevall, A Cassone, F Bistoni, et al.
Journal of Chemotherapy (Florence, Italy)|September 20, 2005
Glucan-associated protein modulations and ultrastructural changes of the cell wall in Candida albicans treated with micafungin, a water-soluble, lipopeptide antimycoticL Angiolella, B Maras, A R Stringaro, et al.
Pageof 22